L-Aspase 10000 IU Injection

Regulated Product — Business License Required

B2B and export product information for licensed and authorized business customers. Contact our team regarding bulk supply, documentation, and applicable commercial, import, and export requirements. This page is not a storefront and no purchasing, checkout, or pricing is offered here.

Product photography not yet supplied — this space will show official packaging imagery once provided by the business.

Product Overview

L-Aspase 10000 IU Injection contains L-asparaginase, an enzyme-based cytotoxic (chemotherapy) medicine. Its labelling describes it for the treatment of cancers related to white blood cells (leukemia), particularly acute lymphocytic leukemia, and it may be prescribed for other cancer types. It is described as interfering with the growth of cancer cells, killing them or stopping the overall process. It can be given alone or in combination with chemotherapy, strictly under a professional doctor’s supervision.

Active ingredient
L-Asparaginase
Strength
10000 IU
Dosage form
Powder for solution for injection
Therapeutic class
Enzyme (antineoplastic)
Regulatory status
Prescription / regulated — confirmed per enquiry and destination market
Availability
Confirmed per enquiry

Product Information

The following description reflects information associated with this product’s labelling. It has not been independently clinically verified by SDO Pharma and is provided for business and product-identification purposes only. It is not medical advice and does not replace the manufacturer’s official prescribing information.

Described Uses

  • Described for the treatment of cancers related to white blood cells (leukemia), particularly acute lymphocytic leukemia
  • Described as also prescribed for other cancer types
  • Described as interfering with the growth of cancer cells to kill or stop the process
Note: SDO Pharma has not independently verified the manufacturer’s efficacy claims for this product and makes no additional medical or clinical claims beyond what is described here. We do not claim FDA, UAE, EU, or other specific regulatory approval for this product unless independently verified. This is a prescription / regulated-status product; patient dispensing is the responsibility of the licensed business customer, not SDO Pharma.

Described Dosage & Administration

  • Given strictly under a professional doctor’s supervision; it should not be given by any non-professional
  • The dosage and duration are decided by the doctor and can change over time; it can be given alone or in combination with chemotherapy
  • Taken at the same time every day for best effect; benefits can take months, and it should not be stopped unless the doctor advises

Described Side Effects

Commonly described side effects include:

  • Breathlessness
  • Rash
  • Nausea and vomiting
  • Fatigue
  • Diarrhoea
  • Decreased blood pressure
  • Flushing (sense of warmth in the face, ears, neck, and trunk)

These are described as commonly temporary. The doctor should be consulted if they persist.

Precautions

  • Extra water should be taken, which helps prevent bladder and kidney problems
  • The medicine can make the body vulnerable to infections
  • Pregnancy or fathering a child should be avoided during treatment; the doctor should be informed if already pregnant
  • Any persistent side effect should be reported to the doctor

This summary is provided for informational purposes only and does not replace the manufacturer’s official product labelling or professional medical advice.

B2B, Import & Export

B2B, Import & Export Enquiries

SDO Pharma supports business enquiries for pharmaceutical and healthcare products, including bulk and export supply, subject to applicable licensing, regulatory, import, and export requirements. Requirements vary according to the destination market and the nature of the transaction.

We do not claim that this product is available for import into every country, and we do not claim FDA, UAE, EU, or other specific regulatory approval unless independently verified. Applicable documentation — including a valid Drug License, tax registration, and Importer Exporter Code (IEC) where relevant — is discussed directly with our team as part of the enquiry process. This is a regulated / prescription-status product supplied only to licensed and authorized business customers; SDO Pharma does not sell it directly to individual patients or consumers. See our Regulated Products Policy.

Product Enquiry

Request Product Information

Interested in this product for your business? Submit your enquiry and our team will contact you regarding bulk supply, documentation, and applicable requirements.

Frequently Asked Questions

Per its labelling it contains L-asparaginase and is used for the treatment of leukemia (cancers related to white blood cells), particularly acute lymphocytic leukemia. SDO Pharma has not independently verified the manufacturer’s claims and does not claim any specific regulatory approval unless independently confirmed.

Its labelling describes it as given strictly under a professional doctor’s supervision, alone or in combination with chemotherapy, at the same time each day.

Licensed and authorized business customers can submit the product enquiry form above or contact our team directly. Product availability, documentation, and supply arrangements are confirmed per enquiry.

Availability depends on the destination market’s regulatory requirements and cannot be confirmed without a direct enquiry. See our B2B, Import & Export Enquiries section above.

Explore More

Related Product Categories

SDO Pharma works across several pharmaceutical and healthcare product categories for business customers.

View Products & Services